Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders.
Adolescent
Adult
Ambulatory Care
/ statistics & numerical data
Anorexia Nervosa
/ therapy
Body Mass Index
Body Weight
Bulimia Nervosa
/ therapy
Confidence Intervals
Feeding and Eating Disorders
/ therapy
Hospitalization
/ statistics & numerical data
Humans
Length of Stay
/ statistics & numerical data
Randomized Controlled Trials as Topic
Remission Induction
Waiting Lists
Young Adult
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
21 Jan 2019
21 Jan 2019
Historique:
pubmed:
22
1
2019
medline:
11
4
2019
entrez:
22
1
2019
Statut:
epublish
Résumé
Clinical guidelines recommend outpatient care for the majority of people with an eating disorder. The optimal use of inpatient treatment or combination of inpatient and partial hospital care is disputed and practice varies widely. To assess the effects of treatment setting (inpatient, partial hospitalisation, or outpatient) on the reduction of symptoms and increase in remission rates in people with:1. Anorexia nervosa and atypical anorexia nervosa;2. Bulimia nervosa and other eating disorders. We searched Ovid MEDLINE (1950- ), Embase (1974- ), PsycINFO (1967- ) and the Cochrane Central Register of Controlled Trials (CENTRAL) to 2 July 2018. An earlier search of these databases was conducted via the Cochrane Common Mental Disorders Controlled Trial Register (CCMD-CTR) (all years to 20 November 2015). We also searched the WHO International Clinical Trials Registry Platform and ClinicalTrials.gov (6 July 2018). We ran a forward citation search on the Web of Science to identify additional reports citing any of the included studies, and screened reference lists of included studies and relevant reviews identified during our searches. We included randomised controlled trials that tested the efficacy of inpatient, outpatient, or partial hospital settings for treatment of eating disorder in adults, adolescents, and children, whose diagnoses were determined according to the DSM-5, or other internationally accepted diagnostic criteria. We excluded trials of treatment setting for medical or psychiatric complications or comorbidities (e.g. hypokalaemia, depression) of an eating disorder. We followed standard Cochrane procedures to select studies, extract and analyse data, and interpret and present results. We extracted data according to the DSM-5 criteria. We used the Cochrane tool to assess risk of bias. We used the mean (MD) or standardised mean difference (SMD) for continuous data outcomes, and the risk ratio (RR) for binary outcomes. We included the 95% confidence interval (CI) with each result. We presented the quality of the evidence and estimate of effect for weight or body mass index (BMI) and acceptability (number who completed treatment), in a 'Summary of findings' table for the comparison for which we had sufficient data to conduct a meta-analysis. We included five trials in our review. Four trials included a total of 511 participants with anorexia nervosa, and one trial had 55 participants with bulimia nervosa. Three trials are awaiting classification, and may be included in future versions of this review. We assessed a risk of bias from lack of blinding of participants and therapists in all trials, and unclear risk for allocation concealment and randomisation in one study.We had planned four comparisons, and had data for meta-analyses for one. For anorexia nervosa, there may be little or no difference between specialist inpatient care and active outpatient or combined brief hospital and outpatient care in weight gain at 12 months after the start of treatment (standardised mean difference (SMD) -0.22, 95% CI -0.49 to 0.05; 2 trials, 232 participants; low-quality evidence). People may be more likely to complete treatment when randomised to outpatient care settings, but this finding is very uncertain (risk ratio (RR) 0.75, 95% CI 0.64 to 0.88; 3 trials, 319 participants; very low-quality evidence). We downgraded the quality of the evidence for these outcomes because of risks of bias, small numbers of participants and events, and variable level of specialist expertise and intensity of treatment.We had no data, or data from only one trial for the primary outcomes for each of the other three comparisons.No trials measured weight or acceptance of treatment for anorexia nervosa, when comparing inpatient care provided by a specialist eating disorder service and health professionals and a waiting list, no active treatment, or treatment as usual.There was no clear difference in weight gain between settings, and only slightly more acceptance for the partial hospital setting over specialist inpatient care for weight restoration in anorexia nervosa.There was no clear difference in weight gain or acceptability of treatment between specialist inpatient care and partial hospital care for bulimia nervosa, and other binge eating disorders. There was insufficient evidence to conclude whether any treatment setting was superior for treating people with moderately severe (or less) anorexia nervosa, or other eating disorders.More research is needed for all comparisons of inpatient care versus alternate care.
Sections du résumé
BACKGROUND
BACKGROUND
Clinical guidelines recommend outpatient care for the majority of people with an eating disorder. The optimal use of inpatient treatment or combination of inpatient and partial hospital care is disputed and practice varies widely.
OBJECTIVES
OBJECTIVE
To assess the effects of treatment setting (inpatient, partial hospitalisation, or outpatient) on the reduction of symptoms and increase in remission rates in people with:1. Anorexia nervosa and atypical anorexia nervosa;2. Bulimia nervosa and other eating disorders.
SEARCH METHODS
METHODS
We searched Ovid MEDLINE (1950- ), Embase (1974- ), PsycINFO (1967- ) and the Cochrane Central Register of Controlled Trials (CENTRAL) to 2 July 2018. An earlier search of these databases was conducted via the Cochrane Common Mental Disorders Controlled Trial Register (CCMD-CTR) (all years to 20 November 2015). We also searched the WHO International Clinical Trials Registry Platform and ClinicalTrials.gov (6 July 2018). We ran a forward citation search on the Web of Science to identify additional reports citing any of the included studies, and screened reference lists of included studies and relevant reviews identified during our searches.
SELECTION CRITERIA
METHODS
We included randomised controlled trials that tested the efficacy of inpatient, outpatient, or partial hospital settings for treatment of eating disorder in adults, adolescents, and children, whose diagnoses were determined according to the DSM-5, or other internationally accepted diagnostic criteria. We excluded trials of treatment setting for medical or psychiatric complications or comorbidities (e.g. hypokalaemia, depression) of an eating disorder.
DATA COLLECTION AND ANALYSIS
METHODS
We followed standard Cochrane procedures to select studies, extract and analyse data, and interpret and present results. We extracted data according to the DSM-5 criteria. We used the Cochrane tool to assess risk of bias. We used the mean (MD) or standardised mean difference (SMD) for continuous data outcomes, and the risk ratio (RR) for binary outcomes. We included the 95% confidence interval (CI) with each result. We presented the quality of the evidence and estimate of effect for weight or body mass index (BMI) and acceptability (number who completed treatment), in a 'Summary of findings' table for the comparison for which we had sufficient data to conduct a meta-analysis.
MAIN RESULTS
RESULTS
We included five trials in our review. Four trials included a total of 511 participants with anorexia nervosa, and one trial had 55 participants with bulimia nervosa. Three trials are awaiting classification, and may be included in future versions of this review. We assessed a risk of bias from lack of blinding of participants and therapists in all trials, and unclear risk for allocation concealment and randomisation in one study.We had planned four comparisons, and had data for meta-analyses for one. For anorexia nervosa, there may be little or no difference between specialist inpatient care and active outpatient or combined brief hospital and outpatient care in weight gain at 12 months after the start of treatment (standardised mean difference (SMD) -0.22, 95% CI -0.49 to 0.05; 2 trials, 232 participants; low-quality evidence). People may be more likely to complete treatment when randomised to outpatient care settings, but this finding is very uncertain (risk ratio (RR) 0.75, 95% CI 0.64 to 0.88; 3 trials, 319 participants; very low-quality evidence). We downgraded the quality of the evidence for these outcomes because of risks of bias, small numbers of participants and events, and variable level of specialist expertise and intensity of treatment.We had no data, or data from only one trial for the primary outcomes for each of the other three comparisons.No trials measured weight or acceptance of treatment for anorexia nervosa, when comparing inpatient care provided by a specialist eating disorder service and health professionals and a waiting list, no active treatment, or treatment as usual.There was no clear difference in weight gain between settings, and only slightly more acceptance for the partial hospital setting over specialist inpatient care for weight restoration in anorexia nervosa.There was no clear difference in weight gain or acceptability of treatment between specialist inpatient care and partial hospital care for bulimia nervosa, and other binge eating disorders.
AUTHORS' CONCLUSIONS
CONCLUSIONS
There was insufficient evidence to conclude whether any treatment setting was superior for treating people with moderately severe (or less) anorexia nervosa, or other eating disorders.More research is needed for all comparisons of inpatient care versus alternate care.
Identifiants
pubmed: 30663033
doi: 10.1002/14651858.CD010827.pub2
pmc: PMC6353082
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD010827Références
Ann N Y Acad Sci. 2000 May;904:614-6
pubmed: 10865814
Aust N Z J Psychiatry. 2014 Nov;48(11):977-1008
pubmed: 25351912
Br J Psychiatry. 1988 Mar;152:367-71
pubmed: 3167372
J Clin Psychol. 2011 Mar;67(3):318-27
pubmed: 21254059
BMJ Clin Evid. 2009 Mar 10;2009:
pubmed: 19445758
Br J Psychiatry. 1991 Sep;159:325-33
pubmed: 1958942
Eat Weight Disord. 2016 Sep;21(3):353-364
pubmed: 26942768
Psychol Med. 2013 Dec;43(12):2477-500
pubmed: 23217606
Biol Psychiatry. 2007 Feb 1;61(3):348-58
pubmed: 16815322
Am J Psychiatry. 2002 Aug;159(8):1284-93
pubmed: 12153817
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Cochrane Database Syst Rev. 2001;(4):CD003385
pubmed: 11687197
Dtsch Arztebl Int. 2011 Oct;108(40):678-85
pubmed: 22114627
J Psychother Pract Res. 2001 Fall;10(4):253-61
pubmed: 11696652
Psychol Med. 1975 Nov;5(4):355-71
pubmed: 1197538
Evid Based Ment Health. 2015 Feb;18(1):20
pubmed: 25239245
Psychother Psychosom. 2009;78(3):152-60
pubmed: 19270470
Am J Psychiatry. 1991 Jul;148(7):917-22
pubmed: 2053633
J Clin Psychol. 2002 Jul;58(7):833-46
pubmed: 12205723
J Adv Nurs. 2005 Jul;51(1):5-14
pubmed: 15941455
Trials. 2011 May 09;12:114
pubmed: 21554734
Int J Eat Disord. 1994 Mar;15(2):165-77
pubmed: 8173562
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004191
pubmed: 16856036
Eur Psychiatry. 2015 Jul;30(5):583-9
pubmed: 25735811
World Psychiatry. 2005 Oct;4(3):142-6
pubmed: 16633532
Psychol Med. 2015 Jan;45(2):415-27
pubmed: 25017941
Psychother Psychosom. 2009;78(5):317-9
pubmed: 19628960
Br J Psychiatry. 2000 Feb;176:138-41
pubmed: 10755050
Pediatr Res. 2000 Jun;47(6):709-12
pubmed: 10832726
Int J Neuropsychopharmacol. 2012 Mar;15(2):209-22
pubmed: 21439105
Am J Psychiatry. 1995 Jul;152(7):1070-2
pubmed: 7793445
Cochrane Database Syst Rev. 2002;(2):CD002891
pubmed: 12076457
Lancet Psychiatry. 2015 Dec;2(12):1099-111
pubmed: 26514083
Br J Psychiatry. 2007 Nov;191:427-35
pubmed: 17978323
Int J Neuropsychopharmacol. 2012 Mar;15(2):189-207
pubmed: 21414249
BMC Psychiatry. 2016 Nov 24;16(1):422
pubmed: 27881106
Lancet. 2000 Feb 26;355(9205):721-2
pubmed: 10703806
PLoS One. 2008 Feb 06;3(2):e1541
pubmed: 18253489
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000562
pubmed: 19821271
Cochrane Database Syst Rev. 2003;(4):CD003391
pubmed: 14583971
Eur Child Adolesc Psychiatry. 2015 May;24(5):537-44
pubmed: 25159090
Arch Gen Psychiatry. 2005 Jul;62(7):776-81
pubmed: 15997019
Br J Psychiatry. 2007 Nov;191:436-40
pubmed: 17978324
Lancet. 2014 Apr 5;383(9924):1222-9
pubmed: 24439238
Int J Eat Disord. 2003 Dec;34(4):383-96
pubmed: 14566926
Cochrane Database Syst Rev. 2015 Jul 27;(7):CD003909
pubmed: 26212713
Int J Eat Disord. 2006 Jan;39(1):62-71
pubmed: 16345055
J Psychiatr Res. 2012 Dec;46(12):1600-9
pubmed: 22981704
Health Technol Assess. 2010 Mar;14(15):1-98
pubmed: 20334748
Am J Psychiatry. 2007 Aug;164(8):1259-65
pubmed: 17671290
Cochrane Database Syst Rev. 2010 Apr 14;(4):CD004780
pubmed: 20393940
Einstein (Sao Paulo). 2016 Apr-Jun;14(2):235-77
pubmed: 27462898
Clin Pract Epidemiol Ment Health. 2011 Mar 04;7:29-37
pubmed: 21559234
BMC Psychiatry. 2013 Nov 15;13:308
pubmed: 24238469
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004365
pubmed: 16437485